Exchange Traded Concepts
KLRA icon

Exchange Traded Concepts’s Kailera Therapeutics KLRA Stock Holding History

Exchange Traded Concepts’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.98M Buy
260,799
+108,298
+71% +$1.83M 0.01% 629
2026
Q2 		$3.36M Buy
+152,501
New +$3.35M 0.02% 569

Other funds holding KLRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Everence Capital Management
Everence Capital Management Goshen, Indiana $1.9B AUM 32.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Exchange Traded Concepts's KLRA Position: Q3 2026 in Review

Exchange Traded Concepts increased its Kailera Therapeutics (KLRA) stake by 71% in Q3 2026, buying an estimated $1.83M and bringing the position to 260,799 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #629.

Exchange Traded Concepts first reported a position in KLRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.36M in Q2 2026. 35 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Exchange Traded Concepts held 260,799 shares of Kailera Therapeutics worth $2.98M as of Q3 2026.
  • Exchange Traded Concepts bought 108,298 Kailera Therapeutics shares in Q3 2026, an estimated $1.83M.
  • Kailera Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q3 2026, its #629 holding.
  • Exchange Traded Concepts first reported a position in Kailera Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Exchange Traded Concepts's Kailera Therapeutics position peaked at $3.36M in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.